Monthly Archives: March 2016

Pensjonering eller fortsatt yrkesaktiv, forlenget påmeldingsfrist i Bergen

Fagakademiet(This post has not been translated, since the course will be held in Norwegian.)

Vi inviterer ansatte i stat, kommuner, fylkeskommune, NAV, helseforetak og andre offentlig eide virksomheter i alderen 60 år og over til kurset. Det er også meget aktuelt for de som går ut av jobb før 60 år p.g.a. særaldersgrense, uføretrygd, førtidspensjon etc. Det er også anledning til å ta med ektefelle/ledsager.
Forelesere: Harald Engelstad og Kurt O. Bjørnnes
Bergen, 04. OG 05. APRIL 2016 Continue reading

Announcement of election to the University Board 2016-2017 for group B

The time has again come for election of a member and deputies to the University Board for the period 1 August 2016 to 31 July 2017; representatives of temporary employees in teaching and research positions (group B).
One member from the group of temporary employees in teaching and research will be elected. In addition, three deputies will be appointed. Proposal Deadline: Wednesday March 31
Election Dates: The election will be electronically conducted during the period 20 -26 April. The polling station is open from Wednesday 20 April 9 am to Tuesday 26 April 12 noon.
Details on how the proposal should be designed and how it should be sent can be found on this page.

COST: New research networks – medical and health research

COST | European Cooperation in Science and TechnologyCOST is a European networking organization where most European countries (including Norway and all EU member states) are members. An important task for COST is to promote European research by initiating scientific networks (“COST actions”).

General information on COST can be found here and here.

In February 2016 it was decided to initiate 26 new COST actions, of which the following is within / relevant for medical and health research: Continue reading

ERPA International Congresses on Education

erpa
Dear Colleague,
It is with great pleasure we inform you about the ERPA International Congresses on Education 2016 that will be held in Sarajevo / Bosnia and Herzegovina from 2 to 4 June 2016.
We hope that the conference will enable you to share your research with an international research community and to engage in discussion about the current issues in the field of education. Continue reading

Eu’s Health Programme – Announcements for 2016 – Free Webinar 22 March

euhp2National Health Service (NHS) in England organizes a webinar 22 March in conjunction with this year’s announcements. I would strongly recommend you to participate if you are interested in applying. They arranged a similar webinar last year, where potential applicants from across the EU participated. Subsequently a list of stakeholders in various topics/projects were prepared . This means that the webinar represents an easy way to get an overview of possible future partners, if desired. Continue reading

New Publications

Based on last week’s search for “Department of Clinical Science AND Bergen”. If you have publications which are not covered by this search, send the reference to elin.opheim@uib.no.

Physicians’ Perception of Teratogenic Risk and Confidence in Prescribing Drugs in Pregnancy-Influence of Norwegian Drug Information Centers.
Bakkebø T, Widnes SF, Aamlid SS, Schjøtt J.
Clin Ther. 2016 Mar 10.

The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis.
Johnsen E, Fathian F, Kroken RA, Steen VM, Jørgensen HA, Gjestad R, Løberg EM.
BMC Psychiatry. 2016 Mar 14;16(1):60.

Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint.
Engblom H, Heiberg E, Erlinge D, Jensen SE, Nordrehaug JE, Dubois-Randé JL, Halvorsen S, Hoffmann P, Koul S, Carlsson M, Atar D, Arheden H.
J Am Heart Assoc. 2016 Mar 9;5(3).

Analysis of cellular and humoral immune responses against cytomegalovirus in patients with autoimmune Addison’s disease.
Edvardsen K, Hellesen A, Husebye ES, Bratland E.
J Transl Med. 2016 Mar 9;14(1):68.

Suggested Cut-Off Values for Vitamin D as a Risk Marker for Total and Cardiac Death in Patients with Suspected Acute Coronary Syndrome.
Naesgaard PA, León de la Fuente RA, Nilsen ST, Pönitz V, Brügger-Andersen T, Grundt H, Staines H, Nilsen DW.
Front Cardiovasc Med. 2016 Feb 26;3:4.

The Hypoglycemic Phenotype is Islet Cell-Autonomous in Short-chain Hydroxyacyl-CoA Dehydrogenase (SCHAD) Deficient Mice.
Molven A, Hollister-Lock J, Hu J, Martinez R, Njølstad PR, Liew CW, Weir G, Kulkarni RN.
Diabetes. 2016 Mar 7.

Equality policy, is that something we in K2 have to think about?

Jone Trovik, portrett til disputasI grew up in a school system with a fairly even distribution of boys and girls with equal skills.

When I was a medical student (early 80s) we were also equally distributed (as opposed to the current situation with 70% girls), but the lecturers were essentially men, and women professors were a rare breed. (I can actually remember that Professor May-Elin Koller of the anesthesia department made an impression as an almost solitary swallow.) In gynecology I have always had many female colleagues and at KK the management also has a dominance of women now.

When I stepped into the University function however, it was like tugging “back to the 80s”: I experience that I am the almost single swallow! Look around your section: How many research groups, platforms or centres of excellence have female leaders? And in middle management, how is the situation there? In the hospital we can clearly see how male nurses largely possess such positions, and how is it for the Medical Laboratory Scientists?

Is this inequality a problem? Should we just sit around and wait for all the current female students and PhD students to grow up an hope that it will then even out? Or should we have an active equality policy where this is on the agenda? A friendly push; actively encourage women to apply for management positions (yes you ARE good enough!) and employ them! Should we have affirmative action? We are currently writing a new strategy document. Should a greater proportion of women in the scientific positions be an objective? If we do not mention it,it means we do not find it important (enough) to work towards. It is a choice.

Jone